https://charts.traderzeitung.de/phases/US80303D3052 string(1395) "{"isin":"US80303D3052","name":"SANUWAVE Health Inc","stock_id_xnas":77834051,"stock_id_xnys":null,"generated_at":"2026-09-24 01:32:00","days":[{"date":"2026-09-21","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":4.46,"close_at":"2026-09-21 21:57:00","complete":true,"perf_pct":null},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-09-22","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":4.54,"close_at":"2026-09-22 21:40:00","complete":true,"perf_pct":1.7937},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-09-23","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":4.785,"close_at":"2026-09-23 18:25:00","complete":true,"perf_pct":5.3965},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":false,"perf_pct":null}]}]}"

Sanuwave Health Aktie News & Nachrichten

[WKN: A40LMS | Symbol: SNWV]

Realtimekurs

SANUWAVE Health Inc is a medical device company providing directed energy products into the wound care space. It is focused on the commercialization of its patented regenerative medicine utilizing noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. Sanuwave's patented, FDA-cleared, and commercialised product is the UltraMIST system, which is used to treat a variety of acute and chronic wounds using ultrasound technology. The company operates in one reportable segment, the design and sale of medical devices. Geographically, the company generates revenue mainly from the United States.

10J

Alles

Vorbörsliche Indikationen

Regulärer Handel

Nachbörslicher Handel

Artikel aus der Redaktion der Trader-Zeitung

Es konnten keine Nachrichten über Sanuwave Health gefunden werden.

Sanuwave Health Nachrichtenticker öffnen

MT Newswires 13.07.2026 22:55 Uhr

Sanuwave Healths vorläufige Q2-Umsatzerlöse übertreffen revidierte Prognose

04:54 PM EDT, 07/13/2026 (MT Newswires) -- Sanuwave Health (SNWV) teilte am Montag mit, dass die Q2-Umsatzerlöse nun voraussichtlich $9.6 million bis

MT Newswires 16.06.2026 20:30 Uhr

Top Mittagsverlierer

02:29 PM EDT, 06/16/2026 (MT Newswires) -- Der Umsatz von Sanuwave Health (SNWV) im zweiten Quartal wird voraussichtlich zwischen 8,5 Millionen und 9,